Skip to Content

VIVUS 3.75/23 (Qsymia phentermine hydrochloride 3.75 mg (base) / topiramate extended-release 23 mg)

Generic Name: phentermine/topiramate

Pill with imprint VIVUS 3.75/23 is Purple, Capsule-shape and has been identified as Qsymia phentermine hydrochloride 3.75 mg (base) / topiramate extended-release 23 mg. It is supplied by Vivus, Inc..

Qsymia is used in the treatment of weight loss; obesity and belongs to the drug class anorexiants. Not for use in pregnancy. Qsymia phentermine hydrochloride 3.75 mg (base) / topiramate extended-release 23 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for VIVUS 3.75/23

Qsymia

Generic Name:
phentermine/topiramate
Imprint:
VIVUS 3.75/23
Strength:
phentermine hydrochloride 3.75 mg (base) / topiramate extended-release 23 mg
Color:
Purple
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Anorexiants
Pregnancy Category:
X - Not for use in pregnancy
CSA Schedule:
4 - Some potential for abuse
Labeler / Supplier:
Vivus, Inc.
Inactive Ingredients:
sucrose
corn starch
microcrystalline cellulose
ethylcelluloses
povidone k30
gelatin
magnesium silicate
titanium dioxide
FD&C Blue No. 1
FD&C Red No. 3
Note: Inactive ingredients may vary.

Submitted by: pillstress

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide